Opiant Pharmaceuticals公司的背景是什麼？

詳細公司背景可參考: [https://www.opiant.com](https://www.opiant.com)。

Opiant Pharmaceuticals

OPNT

13.120

▼0.670

▼4.86%

概況消息

最少15分鐘延遲，股票資訊由第三方資訊供應商提供

・Opiant Pharmaceuticals - 延遲價格・最後更新於 24/05 8:00

最高位: 13.280
最低位: 12.810
開市價: --
前收市價: 13.790
成交量(千): 1.11
成交額(百萬): 0.13
買入: --
賣出: --
每手股數: --
市值(百萬): 66.74
市盈率: --
息率: --
差價: --
52週高低: 37.711 - 7.340

所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱: Opiant Pharmaceuticals
證券代碼: OPNT.US
所屬板塊: Biotechnology
公司業務: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.
發行量: 5069605
公司總部: 233 Wilshire Boulevard, Suite 280
公司網址: https://www.opiant.com
公司電郵: Investor.relations@opiant.com
公司電話: +1 310 598-5410

關於

Opiant Pharmaceuticals(OPNT.US)所屬的行業板塊為Biotechnology。

Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.

詳細公司背景可參考: https://www.opiant.com。

快訊

資訊

虛擬市場

Opiant Pharmaceuticals

企業資料

最新發佈

關於